117 related articles for article (PubMed ID: 12494449)
21. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
[TBL] [Abstract][Full Text] [Related]
22. Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.
Koda M; Sulkowski S; Garofalo C; Kanczuga-Koda L; Sulkowska M; Surmacz E
Horm Metab Res; 2003; 35(11-12):794-801. PubMed ID: 14710360
[TBL] [Abstract][Full Text] [Related]
23. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C; Tencer L; Ravid D; Sarfstein R; Liscovitch M; Werner H
Exp Cell Res; 2006 Nov; 312(19):3899-908. PubMed ID: 17014845
[TBL] [Abstract][Full Text] [Related]
24. The insulin-like growth factor axis in cell cycle progression.
Dupont J; Pierre A; Froment P; Moreau C
Horm Metab Res; 2003; 35(11-12):740-50. PubMed ID: 14710353
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
26. Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells.
Carelli S; Di Giulio AM; Paratore S; Bosari S; Gorio A
J Cell Physiol; 2006 Aug; 208(2):354-62. PubMed ID: 16619240
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
28. Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer.
Koda M; Przystupa W; Jarzabek K; Wincewicz A; Kanczuga-Koda L; Tomaszewski J; Sulkowska M; Wolczynski S; Sulkowski S
Oncol Rep; 2005 Jul; 14(1):93-8. PubMed ID: 15944774
[TBL] [Abstract][Full Text] [Related]
29. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.
Surmacz E
Oncogene; 2003 Sep; 22(42):6589-97. PubMed ID: 14528284
[TBL] [Abstract][Full Text] [Related]
30. The contradictions of the insulin-like growth factor 1 receptor.
Baserga R
Oncogene; 2000 Nov; 19(49):5574-81. PubMed ID: 11114737
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.
van Golen CM; Schwab TS; Kim B; Soules ME; Su Oh S; Fung K; van Golen KL; Feldman EL
Cancer Res; 2006 Jul; 66(13):6570-8. PubMed ID: 16818629
[TBL] [Abstract][Full Text] [Related]
34. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
35. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
36. Function of the IGF-I receptor in breast cancer.
Surmacz E
J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):95-105. PubMed ID: 10791772
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.
Hua H; Kong Q; Yin J; Zhang J; Jiang Y
J Hematol Oncol; 2020 Jun; 13(1):64. PubMed ID: 32493414
[TBL] [Abstract][Full Text] [Related]
38. Type I insulin-like growth factor receptor function in breast cancer.
Surmacz E; Guvakova MA; Nolan MK; Nicosia RF; Sciacca L
Breast Cancer Res Treat; 1998 Feb; 47(3):255-67. PubMed ID: 9516080
[TBL] [Abstract][Full Text] [Related]
39. Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells.
Goldfine ID; Papa V; Vigneri R; Siiteri P; Rosenthal S
Breast Cancer Res Treat; 1992; 22(1):69-79. PubMed ID: 1421426
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression.
Werner H
Mol Cell Endocrinol; 1998 Jun; 141(1-2):1-5. PubMed ID: 9723878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
